Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$8.11 - $11.11 $470,809 - $644,968
-58,053 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$9.85 - $17.69 $6,589 - $11,834
669 Added 1.17%
58,053 $611,000
Q4 2020

Feb 02, 2021

SELL
$14.15 - $17.19 $375,866 - $456,617
-26,563 Reduced 31.64%
57,384 $888,000
Q3 2020

Nov 05, 2020

SELL
$14.14 - $19.71 $133,594 - $186,220
-9,448 Reduced 10.12%
83,947 $1.23 Million
Q2 2020

Jul 22, 2020

BUY
$16.6 - $25.25 $1.55 Million - $2.36 Million
93,395 New
93,395 $1.77 Million
Q2 2019

Jul 30, 2019

SELL
$4.32 - $6.43 $170,765 - $254,171
-39,529 Closed
0 $0
Q1 2019

May 09, 2019

SELL
$4.12 - $10.25 $530,000 - $1.32 Million
-128,641 Reduced 76.49%
39,529 $231,000
Q4 2018

Feb 07, 2019

BUY
$8.2 - $16.95 $1.38 Million - $2.85 Million
168,170 New
168,170 $1.58 Million

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $490M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.